Stock return outliers and beta estimation : the case of U.S. pharmaceutical companies
Year of publication: |
2014
|
---|---|
Authors: | Theodossiou, Alexandra K. ; Theodossiou, Panayiotis |
Published in: |
Journal of international financial markets, institutions & money. - Amsterdam : Elsevier, ISSN 1042-4431, ZDB-ID 1117317-8. - Vol. 30.2014, p. 153-171
|
Subject: | OLS estimation | Robust M estimation | Stock beta | Equity cost of capital | Pharmaceutical industry | Pharmaindustrie | USA | United States | Schätztheorie | Estimation theory | Kapitaleinkommen | Capital income | Betafaktor | Beta risk | Börsenkurs | Share price | Schätzung | Estimation | CAPM | Kleinste-Quadrate-Methode | Least squares method | Kapitalkosten | Cost of capital |
-
Scheler, Fabian, (2017)
-
Beta Estimation with Stock Return Outliers : The Case of U.S. Pharmaceutical Companies
Theodossiou, Alexandra K., (2009)
-
CAPM with fuzzy returns and hypothesis testing
Moussa, A. Mbairadjim, (2014)
- More ...
-
Stock return outliers and beta estimation: The case of U.S. pharmaceutical companies
Theodossiou, Alexandra K., (2014)
-
Beta Estimation with Stock Return Outliers : The Case of U.S. Pharmaceutical Companies
Theodossiou, Alexandra K., (2009)
-
Event Studies and Outlier Returns : Symptoms, Consequences and Treatment
Theodossiou, Panayiotis, (2019)
- More ...